标题
β-Lactam antimicrobials: what have you done for me lately?
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1277, Issue 1, Pages 76-83
出版商
Wiley
发表日期
2012-11-30
DOI
10.1111/j.1749-6632.2012.06809.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Characterization of Extended-Spectrum-β-Lactamase-Producing and Plasmid-Mediated AmpC β-Lactamase-Producing Escherichia coli Isolated from Stray Dogs in South Korea
- (2012) Migma Dorji Tamang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased Susceptibility to Noncarbapenem Antimicrobials in Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Toronto, Canada
- (2012) Christopher F. Lowe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette ChromosomemecTypes
- (2012) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiologic Characteristics of Cephalosporin-Resistant Escherichia coli at Three Centers in the United States
- (2012) Yoon Soo Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Summary of Ceftaroline Activity against Pathogens in the United States, 2010: Report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program
- (2012) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
- (2012) Meredith G. Jernigan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) andblaCTX-M-15among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009
- (2012) James R. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diverse Sequence Types of Klebsiella pneumoniae Contribute to the Dissemination ofblaNDM-1in India, Sweden, and the United Kingdom
- (2012) Christian G. Giske et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild Coastline Birds as Reservoirs of Broad-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Miami Beach, Florida
- (2012) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates
- (2012) Premavathy Levasseur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010
- (2012) Guillermo V. Sanchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health
- (2012) George H. Talbot et al. CLINICAL INFECTIOUS DISEASES
- Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City
- (2012) Hemavarna Tiruvury et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone
- (2012) Todd A. Davies et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum -lactamase-producing Escherichia coli
- (2012) N. Lampri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Perpetual Challenge of Infectious Diseases
- (2012) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- CTX-M Enzymes: Origin and Diffusion
- (2012) Rafael Cantón et al. Frontiers in Microbiology
- Molecular Characterization of Resistance to Extended-Spectrum Cephalosporins in Clinical Escherichia coli Isolates from Companion Animals in the United States
- (2011) Bashar W. Shaheen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoProperties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases
- (2011) Malcolm G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New antimicrobial agents on the horizon
- (2011) Karen Bush et al. BIOCHEMICAL PHARMACOLOGY
- Will new antimicrobials overcome resistance among Gram-negatives?
- (2011) Matteo Bassetti et al. Expert Review of Anti-Infective Therapy
- Antimicrobial Stewardship
- (2011) Pranita D. Tamma et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Metallo-β-lactamases: a last frontier for β-lactams?
- (2011) Giuseppe Cornaglia et al. LANCET INFECTIOUS DISEASES
- Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of CXA-101, a New Antipseudomonal Cephalosporin, in Healthy Adult Male and Female Subjects Receiving Single- and Multiple-Dose Intravenous Infusions
- (2010) Y. Ge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
- (2010) Karen Bush CURRENT OPINION IN MICROBIOLOGY
- Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria
- (2010) A. Pallett et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Hospital-Acquired Infections Due to Gram-Negative Bacteria
- (2010) Anton Y. Peleg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and novel antibiotics against resistant Gram-positive bacteria
- (2010) Federico Perez Infection and Drug Resistance
- Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains
- (2009) C. Juan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Extended‐Spectrum β‐Lactamase–ProducingEscherichiacoliin Community Hospitals throughout North Carolina: A Harbinger of a Wider Problem in the United States?
- (2009) Joshua T. Freeman et al. CLINICAL INFECTIOUS DISEASES
- Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates
- (2009) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Has the era of untreatable infections arrived?
- (2009) D. M. Livermore JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
- (2009) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
- (2008) G. J. Noel et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
- (2008) Alicia I. Hidron et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now